Literature DB >> 25619919

Development of a model for robust and exploratory analysis of the rodent brief-access taste aversion data.

Jessica Soto1, Yucheng Sheng1, Joseph F Standing1, Mine Orlu Gul1, Catherine Tuleu2.   

Abstract

The rodent brief-access taste aversion (BATA) model is an efficient in vivo screening tool for taste assessment. A new E(max) (maximum effect attributable to the drug) model was developed and further investigated in comparison with three previously published models for analysing the rodent BATA data; the robustness of all the models was discussed. The rodent BATA data were obtained from a series of experiments conducted with a bitter reference compound, quinine hydrochloride dihydrate (QHD). A new E(max) model that could be applied to both "lick numbers" and "lick ratios" was built and three published models that used lick ratios were employed for analysing the BATA data. IC50, the concentration that inhibits 50% of the maximum lick numbers, quantified the oral aversiveness of QHD. One thousand bootstrap datasets were generated from the original data. All models were applied to estimate the confidence intervals of the IC50s without symmetric assumption. The IC50 value obtained from the new E(max) model was 0.0496 mM (95% CI 0.0297-0.0857) using the lick numbers for analysis, while an IC50 of 0.0502 mM (95% CI 0.0267-0.0859) was acquired with the lick ratios. Except one published model, the IC50 values have a similar range for the 95% CI. The new E(max) model enabled the analysis of both "lick numbers" and "lick ratios" whereas other models could only handle data presented as "lick ratios". IC50s obtained with these two types of datasets showed similarity among all models thereby justified the robustness of the new E(max) model.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bitterness; Brief-access taste aversion; E(max) model; Lickometer; NONMEM; Quinine

Mesh:

Substances:

Year:  2015        PMID: 25619919     DOI: 10.1016/j.ejpb.2015.01.016

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  6 in total

1.  Development and evaluation of an oral fast disintegrating anti-allergic film using hot-melt extrusion technology.

Authors:  Manjeet B Pimparade; Anh Vo; Abhijeet S Maurya; Jungeun Bae; Joseph T Morott; Xin Feng; Dong Wuk Kim; Vijay I Kulkarni; Roshan Tiwari; K Vanaja; Reena Murthy; H N Shivakumar; D Neupane; S R Mishra; S N Murthy; Michael A Repka
Journal:  Eur J Pharm Biopharm       Date:  2017-06-06       Impact factor: 5.571

2.  BitterMatch: recommendation systems for matching molecules with bitter taste receptors.

Authors:  Eitan Margulis; Yuli Slavutsky; Tatjana Lang; Maik Behrens; Yuval Benjamini; Masha Y Niv
Journal:  J Cheminform       Date:  2022-07-07       Impact factor: 8.489

3.  New generalized poisson mixture model for bimodal count data with drug effect: An application to rodent brief-access taste aversion experiments.

Authors:  Y Sheng; J Soto; M Orlu Gul; M Cortina-Borja; C Tuleu; J F Standing
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-07-29

4.  Multi-Methodological Quantitative Taste Assessment of Anti-Tuberculosis Drugs to Support the Development of Palatable Paediatric Dosage Forms.

Authors:  Alison V Keating; Jessica Soto; Claire Forbes; Min Zhao; Duncan Q M Craig; Catherine Tuleu
Journal:  Pharmaceutics       Date:  2020-04-17       Impact factor: 6.321

5.  Evaluating the Taste Masking Ability of Two Novel Dispersible Tablet Platforms Containing Zinc Sulfate and Paracetamol Reconstituted in a Breast Milk Substitute.

Authors:  Samuel Orubu; Richard A Kendall; Yucheng Sheng; Catherine Tuleu
Journal:  Pharmaceutics       Date:  2022-02-15       Impact factor: 6.321

6.  Quantitative prediction of the bitterness of atomoxetine hydrochloride and taste-masked using hydroxypropyl-β-cyclodextrin: A biosensor evaluation and interaction study.

Authors:  Shuying Li; Ying Zhang; Abdur Rauf Khan; Shuwang He; Yingxin Wang; Jiangkang Xu; Guangxi Zhai
Journal:  Asian J Pharm Sci       Date:  2019-11-26       Impact factor: 6.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.